Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2023

08.08.2022 | Maternal-Fetal Medicine

Late amniocentesis: better late than never? A single referral centre experience

verfasst von: Akshatha Sharma, Anita Kaul

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Several congenital abnormalities present late in pregnancy necessitating invasive testing to rule out genetic/infectious causes at late gestation. Not many studies have described the indications/safety of a late gestation amniocentesis.

Methods

All records of amniocentesis performed beyond 24 weeks were reviewed and evaluated for indications, positive yield and complications.

Results

About 187 women had an amniocentesis after 24 weeks for various indications with CNS abnormalities being the commonest. The total yield of positive findings was 14.60% (22/150; excluding 2 VOUS). CNS, multiple system involvement and skeletal system anormalities yielded maximum results. About 32.05% abnormalities could have potentially been detected at the time of a routine anomaly scan. Amongst all the deliveries, 2.1%  delivered spontaneously within a week of the procedure and about 5.4% delivered spontaneously within a month of the procedure.

Conclusion

The study emphasises the need for additional accreditation (FMF, ISUOG) of sonographers to ensure the detection of anomalies at the routine 18–20 weeks scan. Inspite of a normal mid-trimester scan, central nervous system and gastrointestinal abnormalities presented more commonly after 24 weeks. The high positive yield in our study highlights the importance of testing even in late pregnancy beyond the legal age of termination. The test could clearly stratify the pregnancies with a poor outcome whilst reassuring the others. The procedure itself did not lead to a neonatal death due to prematurity.
Literatur
1.
Zurück zum Zitat Akolekar R, Beta J, Picciarelli G et al (2015) Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 45(1):16–26CrossRefPubMed Akolekar R, Beta J, Picciarelli G et al (2015) Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 45(1):16–26CrossRefPubMed
2.
Zurück zum Zitat Malinger G, Lerman-Sagie T, Watemberg N et al (2002) A normal second-trimester ultrasound does not exclude intracranial structural pathology. Ultrasound Obstet Gynecol. 20(1):51–56CrossRefPubMed Malinger G, Lerman-Sagie T, Watemberg N et al (2002) A normal second-trimester ultrasound does not exclude intracranial structural pathology. Ultrasound Obstet Gynecol. 20(1):51–56CrossRefPubMed
4.
Zurück zum Zitat The Medical Termination of Pregnancy (Amendment) Act, 2021. The Gazette of India, No. 8 of 2021 The Medical Termination of Pregnancy (Amendment) Act, 2021. The Gazette of India, No. 8 of 2021
5.
Zurück zum Zitat Geffen KT, Ben-Zvi O, Weitzner O et al (2017) The yield and complications of amniocentesis performed after 24 weeks of gestation. Arch Gynecol Obstet 296(1):69–77CrossRefPubMed Geffen KT, Ben-Zvi O, Weitzner O et al (2017) The yield and complications of amniocentesis performed after 24 weeks of gestation. Arch Gynecol Obstet 296(1):69–77CrossRefPubMed
6.
Zurück zum Zitat Daum H, David AB, Nadjari M et al (2019) The impact of late amniocentesis in the modern genomic technologies era. Ultrasound Obstet Gynecol 53:676–685CrossRefPubMed Daum H, David AB, Nadjari M et al (2019) The impact of late amniocentesis in the modern genomic technologies era. Ultrasound Obstet Gynecol 53:676–685CrossRefPubMed
7.
Zurück zum Zitat O’Donoghue K, Giorgi L, Pontello V et al (2007) Amniocentesis in the third trimester of pregnancy. Prenat Diagn 27:1000–1004CrossRefPubMed O’Donoghue K, Giorgi L, Pontello V et al (2007) Amniocentesis in the third trimester of pregnancy. Prenat Diagn 27:1000–1004CrossRefPubMed
8.
Zurück zum Zitat Drummond CL, Molina-Gomes D, Senat MV (2003) Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population. Prenat Diagn 23:1068–1072CrossRefPubMed Drummond CL, Molina-Gomes D, Senat MV (2003) Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population. Prenat Diagn 23:1068–1072CrossRefPubMed
9.
Zurück zum Zitat Bardin R (2018) Eran Hadara,*, lylach haizler-cohen, rinat gabbay-benziv, et al cytogenetic analysis in fetuses with late onset abnormal sonographic findings. J Perinat Med 46(9):975–982CrossRefPubMed Bardin R (2018) Eran Hadara,*, lylach haizler-cohen, rinat gabbay-benziv, et al cytogenetic analysis in fetuses with late onset abnormal sonographic findings. J Perinat Med 46(9):975–982CrossRefPubMed
10.
Zurück zum Zitat Ficara A, Syngelaki A, Hammami A, Akolekar R, Nicolaides KH (2020) Value of routine ultrasound examination at 35–37 weeks’ gestation in diagnosis of fetal abnormalities. Ultrasound Obstet Gynecol 55(1):75–80CrossRefPubMed Ficara A, Syngelaki A, Hammami A, Akolekar R, Nicolaides KH (2020) Value of routine ultrasound examination at 35–37 weeks’ gestation in diagnosis of fetal abnormalities. Ultrasound Obstet Gynecol 55(1):75–80CrossRefPubMed
11.
Zurück zum Zitat Gagnon S, Fraser W, Fouquette B et al (1992) Nature and frequency of chromosomal abnormalities in pregnancies with abnormal ultrasound findings: an analysis of 117 cases with review of the literature. Prenat Diagn 12:9–18CrossRefPubMed Gagnon S, Fraser W, Fouquette B et al (1992) Nature and frequency of chromosomal abnormalities in pregnancies with abnormal ultrasound findings: an analysis of 117 cases with review of the literature. Prenat Diagn 12:9–18CrossRefPubMed
12.
Zurück zum Zitat Borrell A, Grande M (2017) Eva meler joan sabrià; genomic microarray in fetuses with early growth restriction: a multicenter study. Fetal Diagn Ther 42:174–180CrossRefPubMed Borrell A, Grande M (2017) Eva meler joan sabrià; genomic microarray in fetuses with early growth restriction: a multicenter study. Fetal Diagn Ther 42:174–180CrossRefPubMed
13.
Zurück zum Zitat O’Donoghue K, Giorgi L (2007) Valentina pontello; amniocentesis in the third trimester of pregnancy. Prenat Diagn 27:1000–1004CrossRefPubMed O’Donoghue K, Giorgi L (2007) Valentina pontello; amniocentesis in the third trimester of pregnancy. Prenat Diagn 27:1000–1004CrossRefPubMed
14.
Zurück zum Zitat Michael C (2002) Gordon, komal narula, richard o’shaughnessy, et al; complications of third-trimester amniocentesis using continuous ultrasound guidance. Obstet Gynecol 99(2):255–259 Michael C (2002) Gordon, komal narula, richard o’shaughnessy, et al; complications of third-trimester amniocentesis using continuous ultrasound guidance. Obstet Gynecol 99(2):255–259
15.
Zurück zum Zitat Hodor JG, Poggi SH, Spong CY (2006) Risk of third-trimester amniocentesis a case-control study. Am J Perinatol 23(3):177–180CrossRefPubMed Hodor JG, Poggi SH, Spong CY (2006) Risk of third-trimester amniocentesis a case-control study. Am J Perinatol 23(3):177–180CrossRefPubMed
16.
Zurück zum Zitat Toutain J, Lemaire-Coustel MA, Begorre M et al (2012) Proportion of parents agreeing to delay fetal karyotyping until the third trimester of pregnancy in cases with an indication. Fetal Diagn Ther 31:115–121CrossRefPubMed Toutain J, Lemaire-Coustel MA, Begorre M et al (2012) Proportion of parents agreeing to delay fetal karyotyping until the third trimester of pregnancy in cases with an indication. Fetal Diagn Ther 31:115–121CrossRefPubMed
17.
Zurück zum Zitat Gabbay R, Yogev Y, Melamed N et al (2012) Pregnancy outcome after third trimester amniocentesis: a single center experience. J Matern Fetal Neonatal Med 25(6):666–668CrossRef Gabbay R, Yogev Y, Melamed N et al (2012) Pregnancy outcome after third trimester amniocentesis: a single center experience. J Matern Fetal Neonatal Med 25(6):666–668CrossRef
18.
Zurück zum Zitat Picone O, Senat M-V, Rosenblatt J, Audibert F, Tachdjian G (2008) Rene frydman; fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis? Fetal Diagn Ther 23:30–35CrossRefPubMed Picone O, Senat M-V, Rosenblatt J, Audibert F, Tachdjian G (2008) Rene frydman; fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis? Fetal Diagn Ther 23:30–35CrossRefPubMed
19.
Zurück zum Zitat Salomon J, Sotiriadis A, Wulff CB, Odibo A, Akolekar R (2019) Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol 54(4):442–451CrossRefPubMed Salomon J, Sotiriadis A, Wulff CB, Odibo A, Akolekar R (2019) Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol 54(4):442–451CrossRefPubMed
Metadaten
Titel
Late amniocentesis: better late than never? A single referral centre experience
verfasst von
Akshatha Sharma
Anita Kaul
Publikationsdatum
08.08.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2023
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-022-06662-6

Weitere Artikel der Ausgabe 2/2023

Archives of Gynecology and Obstetrics 2/2023 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.